Endpoints NewsAmarin claims a big win for its cardio outcomes study on Vascepa — and you can bet that makes some people very ...Endpoints NewsAmarin $AMRN has staked its claim to the next big blockbuster in the cardio space, heralding a clear statistical win on the primary endpoint for its 7-year clinical quest to prove that its industrial strength purified fish oil Vascepa can significantly ...In Blowout, Amarin's Fish-Oil-Derived Drug Dramatically Cuts Heart Risk In StudyForbesall 25 news articles »